Mechanistic description
MAP6 stability activity may suppress adjacent tau lability activity through direct physical interaction or by altering tubulin post-translational modifications
Prediction: MAP6 overexpression will extend stability into adjacent tau-rich regions; MAP6 knockout will extend lability into MAP6-rich regions
Mechanism / pathway
- MAP6
- neurodegeneration
Evidence for (5)
Tau and MAP6 establish labile and stable domains on microtubules.
Antagonistic roles of tau and MAP6 in regulating neuronal development.
BioID2-Based Tau Interactome Reveals Novel and Known Protein Interactions Associated with Multiple Cellular Pathways.
Tau: It's Not What You Think.
Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories.
Evidence against (2)
Tau/MAP6 antagonism is shown in neuronal development models, but this does not establish that the same balance drives adult neurodegeneration progression or treatment response.
A microtubule-stabilizing peptide strategy failed to show clinical benefit in progressive supranuclear palsy, cautioning against simple cytoskeletal-stabilization translation in tauopathy.
Evidence matrix
Supporting
- MAP6 stability activity may suppress adjacent tau lability activity through direct physical interaction or by altering tubulin post-translational modifications
- Tau and MAP6 establish labile and stable domains on microtubules. PMID:40040809 · 2025 · iScience
- Antagonistic roles of tau and MAP6 in regulating neuronal development. PMID:39257379 · 2024 · J Cell Sci
- BioID2-Based Tau Interactome Reveals Novel and Known Protein Interactions Associated with Multiple Cellular Pathways. PMID:40910579 · 2025 · J Proteome Res
- Tau: It's Not What You Think. PMID:30929793 · 2019 · Trends Cell Biol
- Beyond Neuronal Microtubule Stabilization: MAP6 and CRMPS, Two Converging Stories. PMID:34025352 · 2021 · Front Mol Neurosci
Contradicting
- Tau/MAP6 antagonism is shown in neuronal development models, but this does not establish that the same balance drives adult neurodegeneration progression or treatment response. PMID:39257379 · 2024 · J Cell Sci
- A microtubule-stabilizing peptide strategy failed to show clinical benefit in progressive supranuclear palsy, cautioning against simple cytoskeletal-stabilization translation in tauopathy. PMID:24873720 · 2014 · Lancet Neurol
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Domain boundary cross-talk hypothesis. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-5a50ce127718
@misc{scidex_hypothesis_h5a50ce1,
title = {Domain boundary cross-talk hypothesis},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-5a50ce127718},
note = {SciDEX artifact hypothesis:h-5a50ce127718}
}